PT141 Melanotan 2 Research Stack – What is Melanotan 2?
Melanotan 2 (MT-2) is a lab-created peptide designed to mimic the effects of the natural hormone alpha-melanocyte-stimulating hormone (α-MSH). This innovative compound has been studied for its potential benefits, including enhancing skin pigmentation (melanogenesis), boosting libido, aiding in weight management, reducing compulsive behaviors, and even showing promise in addressing symptoms associated with Autism Spectrum Disorder (ASD).

PT141 Melanotan 2 Research Stack – Melanotan 2 and Skin Pigmentation
MT-2 is widely recognized for its ability to stimulate melanin production, offering a “sunless tanning” effect. It works by activating melanocortin receptors, primarily MC-1R and MC-4R, which play key roles in skin darkening and other physiological processes. MC-1R is found in skin melanocytes and is responsible for melanin synthesis, while MC-4R influences sexual arousal and appetite regulation.

Important Note: While MT-2 can promote tanning without sun exposure, its long-term safety profile remains under investigation. There is potential concern that it may stimulate the growth of existing skin cancer cells. Always consult a healthcare professional before use.

PT141 Melanotan 2 Research Stack – Melanotan 2 and Weight Management
Research indicates that MT-2 may help reduce fat storage and suppress appetite. It mimics the effects of leptin, a hormone that regulates hunger and energy balance. By activating the MC-4R pathway and increasing thyrotropin-releasing hormone (TRH) expression, MT-2 promotes feelings of fullness and reduces caloric intake. Animal studies have shown that MT-2 decreases dietary fat consumption, making it a promising candidate for weight management research.

PT141 Melanotan 2 Research Stack – MT-2 and Impulse Control
MT-2 has shown potential in reducing addictive behaviors and improving impulse control. Studies on animal models suggest that it can decrease alcohol consumption and increase water intake. When combined with Naltrexone, MT-2 significantly reduces alcohol cravings, highlighting its potential as a therapeutic agent for addiction management.

PT141 Melanotan 2 Research Stack – Melanotan 2 and Autism Spectrum Disorder
In preclinical studies, MT-2 has demonstrated the ability to reverse certain ASD-related behaviors. It enhances oxytocin receptor expression, which is linked to improved social interaction and communication while reducing repetitive behaviors. These findings suggest a potential role for MT-2 in addressing neurological and behavioral aspects of ASD.

PT141 Melanotan 2 Research Stack – MT-2 for Libido and Erectile Dysfunction
MT-2 has been studied for its ability to enhance sexual arousal and treat erectile dysfunction (ED). In clinical trials, it has shown an 80% success rate in cases where other ED medications failed. Unlike traditional ED drugs, MT-2 acts on the central nervous system, offering a broader range of therapeutic effects for both men and women experiencing sexual desire disorders.

PT141 Melanotan 2 Research Stack – Melanotan 2 and Neurodegenerative Diseases
Emerging research suggests that MT-2 may have neuroprotective properties. In studies on Alzheimer’s disease, MT-2 has been shown to reduce beta-amyloid accumulation and decrease neurotoxic reactive astrocytes, which are associated with neuron death. While more research is needed, these findings indicate potential applications for MT-2 in combating neurodegenerative conditions.

Product Details

• CAS Number: 121062-08-6
• Molecular Formula: C50H69N15O9
• Sequence: Ac-Nle-cyclo [Asp-His-D-Phe-Arg-Trp-Lys]-NH2
• Molar Mass: 1,024.18 g/mol
• Half-Life: Approximately 2 hours
• Purity: Minimum 96% (includes stabilizing agents)
• Form: Lyophilized powder in a sterile glass vial
• Dosage: 10mg per vial
• Storage: Refrigerate after reconstitution

Disclaimer: This product is intended solely for in vitro research purposes by qualified professionals. It is not approved for human or animal consumption, nor is it classified as a drug, supplement, or cosmetic.

References

1. Melanotan-II reverses autistic features in a maternal immune activation mouse model of autism. PLoS One. 2019.
2. The leptin-dependent and -independent melanocortin signaling system: regulation of feeding and energy expenditure. J Endocrinol. 2007.
3. Melanocortin activity in the amygdala influences alcohol intake. Pharmacol Biochem Behav. 2011.
4. Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction. J Urol. 1998.
5. Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer’s disease transgenic mouse model. Sci Rep. 2021.